Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedOct 5, 2016Diocto SyrupCGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.Pharmatech LLC · D-1524-2016Class IITerminatedOct 5, 2016Aller-ChlorCGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.Pharmatech LLC · D-1523-2016Class IITerminatedOct 5, 2016Ninjacof-ACGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.Pharmatech LLC · D-1522-2016Class IITerminatedOct 5, 2016NinjacofCGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.Pharmatech LLC · D-1521-2016Class IITerminatedOct 5, 2016SennazonCGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.Pharmatech LLC · D-1520-2016Class IIITerminatedOct 5, 2016Lamotrigine TabletsTablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.Unichem Pharmaceuticals Usa Inc · D-1519-2016Class IIITerminatedSep 28, 2016MozobilLabeling: Incorrect or Missing Lot and/or Exp. DateGenzyme Corporation / Genzyme Biosurgery · D-1518-2016Class IIITerminatedSep 28, 2016Mucinex Sinus-Max Day NightLabeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30...Reckitt Benckiser LLC · D-1517-2016Class IIITerminatedSep 28, 2016Escitalopram Tablets USP 20 mgLabeling: Incorrect or Missing Lot and/or Expiration DateLupin Limited · D-1516-201Class IIITerminatedSep 28, 2016Amoxicillin For Oral SuspensionLabeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.West-Ward Pharmaceuticals Corp. · D-1515-2016Class IITerminatedSep 28, 2016Phenylephrine HCI InjectionLack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.Sandoz Inc · D-1514-2016Class IITerminatedSep 28, 2016Ephedrine Sulfate InjectionLack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.Sandoz Inc · D-1513-2016Class IITerminatedSep 28, 2016Prostaglandin 200 mcg/ 0.1 mL -- 25 mL GLASS VIALLack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due...W & C dba The Apothecary · D-1512-2016Class IITerminatedSep 28, 2016Papaverine 75 mg / Phentolamine 2.5 mg / Prostaglandin 25 mcg -- 4.2 mL GLASS VIALLack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due...W & C dba The Apothecary · D-1511-2016Class IITerminatedSep 28, 2016Papaverine 30 mg / Phentolamine 1 mg / mL -- 5 mL GLASS VIALLack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due...W & C dba The Apothecary · D-1510-2016Class IITerminatedSep 28, 2016Calcium Gluconate 2.5% -- 20 mL PLASTIC SYRINGELack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due...W & C dba The Apothecary · D-1509-2016Class IITerminatedSep 28, 2016Calcium Gluconate 1% -- 1000 mL VIAFLEX IV BAGLack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due...W & C dba The Apothecary · D-1508-2016Class IIITerminatedSep 28, 2016Carvediol TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries, Inc. · D-1507-2016Class IIITerminatedSep 28, 2016Carvediol TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries, Inc. · D-1506-2016Class IIITerminatedSep 28, 2016Carvediol TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries, Inc. · D-1505-2016Class IIITerminatedSep 28, 2016Carvediol TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries, Inc. · D-1504-2016Class IIITerminatedSep 28, 2016Lisinopril Tablets USPCGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.Lupin Pharmaceuticals Inc. · D-1503-2016Class IIITerminatedSep 28, 2016Lisinopril Tablets USPCGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.Lupin Pharmaceuticals Inc. · D-1502-2016Class IIITerminatedSep 21, 2016buPROPion Hydrochloride Extended-Release TabletsFailed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.Amerisource Health Services · D-1501-2016Class IITerminatedSep 21, 2016DOBUTamine InjectionDiscoloration: Firm received complaints of product discoloration and particulates.Hospira Inc. · D-1500-2016Class IITerminatedSep 21, 2016Pantoprazole Sodium Delayed-Release Tablets USPPresence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product...Aurobindo Pharma USA Inc · D-1499-2016Class IITerminatedSep 14, 2016Ephedrine Sulfate InjectionLack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.Allergy Laboratories, Inc. · D-1498-2016Class IITerminatedSep 14, 2016Ondansetron Injection USP 40 mg/20 mLCGMP DeviationsTeva North America · D-1497-2016Class IITerminatedSep 14, 2016Eptifibatide Injection 75 mg/100 mLCGMP DeviationsTeva North America · D-1496-2016Class IITerminatedSep 14, 2016Linezolid Injection 600 mg/300 mLCGMP DeviationsTeva North America · D-1495-2016Class IITerminatedSep 14, 2016ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mLCGMP DeviationsTeva North America · D-1494-2016Class IIITerminatedSep 14, 2016Amlodipine Besylate Tablets USPCGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.Lupin Limited · D-1493-2016Class IIITerminatedSep 14, 2016Amlodipine Besylate Tablets USPCGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.Lupin Limited · D-1492-2016Class IITerminatedSep 14, 2016Bromocriptine Mesylate Capsules USPFailed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius...Zydus Pharmaceuticals USA Inc · D-1491-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1490-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1489-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1488-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1487-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1486-2016Class IITerminatedSep 14, 2016Dextroamphetamine SaccharateUnit Dose Mispackaging; blister cavities may contain more than one tablet /capsuleAmerisource Health Services · D-1485-2016